Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 4079

NIH halts enrollment in trial for SIGA's mpox antiviral after disappointing data

$
0
0
Another trial for SIGA Technologies' mpox antiviral has failed, and all enrollment has been stopped, the NIH's National Institute of Allergy and Infectious Diseases announced this week. SIGA’s tecovirimat is being investigated in the STOMP ...

Viewing all articles
Browse latest Browse all 4079

Latest Images

Trending Articles



Latest Images